Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:NVC
CUSIPN/A
Phone+1-604-2704344
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-341.55%
Return on EquityN/A
Return on Assets-22.34%
Miscellaneous
EmployeesN/A
Outstanding Shares78,683,000
Neovasc (TSE:NVC) Frequently Asked Questions
What is Neovasc's stock symbol?
Neovasc trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NVC."
How were Neovasc's earnings last quarter?
Neovasc Inc. (TSE:NVC) issued its quarterly earnings results on Wednesday, March, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The company had revenue of $1.56 million for the quarter, compared to the consensus estimate of $1.50 million. View Neovasc's Earnings History.
When is Neovasc's next earnings date?
Who are some of Neovasc's key competitors?
Some companies that are related to Neovasc include Trez Capital Limited Partnership (TZZ), Primero Mining (P), Chinook Energy (CKE), Perpetual Energy (PMT), Concordia International (CXR), Eastern Platinum (ELR), McCoy Global (MCB), FORACO International S.A (FAR), Canadian Zinc (CZN), Horizons Active Cdn Dividend Etf (HAL), TAG Oil (TAO), Touchstone Exploration (TXP), Strongco (SQP), WesternOne (WEQ), LWP Capital (LWP), Enterprise Oilfield Group (E), Arsenal Energy (AEI) and ENTREC (ENT).
Who are Neovasc's key executives?
Neovasc's management team includes the folowing people:
- Paul L. Geyer, Independent Chairman of the Board
- Fred Colen, President, Chief Executive Officer
- Christopher Clark, Chief Financial Officer, Corporate Secretary
- Brian McPherson, Chief Operating Officer
- Vicki Lee Bebeau, Vice President - Clinical Affairs
- Randy Lane, Vice President - Research & Development
- Alexei J. Marko, Director
- Jane H. Hsiao Ph.D., Independent Director (Age 69)
- Douglas Glen Janzen, Independent Director
- William O'Neill, Independent Director (Age 61)
Has Neovasc been receiving favorable news coverage?
News articles about NVC stock have trended somewhat positive this week, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Neovasc earned a coverage optimism score of 0.09 on Accern's scale. They also assigned media coverage about the company an impact score of 46.01 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Neovasc?
Shares of NVC and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Neovasc's stock price today?
One share of NVC stock can currently be purchased for approximately C$1.78.
How big of a company is Neovasc?
Neovasc has a market capitalization of C$25.23 million.
How can I contact Neovasc?
Neovasc's mailing address is 13562 Maycrest Way Suite 5138, RICHMOND, BC V6V 2J7, Canada. The company can be reached via phone at +1-604-2704344.
MarketBeat Community Rating for Neovasc (NVC)
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Neovasc (TSE:NVC) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 4/20/2016 forward)
Neovasc (TSE:NVC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Neovasc (TSE NVC) Insider Trading and Institutional Ownership History
Neovasc (TSE NVC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Neovasc (TSE NVC) News Headlines
| Source: |
|
Neovasc (TSE:NVC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Neovasc (TSE NVC) Stock Chart for Friday, April, 20, 2018
Loading chart…
